Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-000462
Filing Date
2025-01-03
Accepted
2025-01-03 16:30:44
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01032025_040128.html 4  
1 form4-01032025_040128.xml 4 3975
  Complete submission text file 0001415889-25-000462.txt   5542
Mailing Address C/O SOMAXON PHARMACEUTICALS, INC. 10935 VISTA SORRENTO PARKWAY, SUITE 250 SAN DIEGO CA 92130
Business Address
Dorsey Brian (Reporting) CIK: 0001380762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39756 | Film No.: 25506867

Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Issuer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)